Yakob Liawatidewi - 28 Aug 2023 Form 4 Insider Report for Amphastar Pharmaceuticals, Inc. (AMPH)

Role
EVP Corp Admin Center, Director
Signature
/s/ Eva Wen, by power of attorney
Issuer symbol
AMPH
Transactions as of
28 Aug 2023
Net transactions value
-$1,102,900
Form type
4
Filing time
29 Aug 2023, 19:54:15 UTC
Previous filing
06 Jun 2023
Next filing
06 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMPH Common Stock Options Exercise $56,290 +3,319 +4.8% $16.96 72,988 28 Aug 2023 Direct
transaction AMPH Common Stock Options Exercise $111,204 +5,497 +7.5% $20.23 78,485 28 Aug 2023 Direct
transaction AMPH Common Stock Options Exercise $260,600 +20,000 +25% $13.03 98,485 28 Aug 2023 Direct
transaction AMPH Common Stock Sale $1,530,994 -28,816 -29% $53.13 69,669 28 Aug 2023 Direct F1, F2
holding AMPH Common Stock 2,459 28 Aug 2023 See footnote F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMPH Employee Stock Option (right to buy) Options Exercise $0 -3,319 -100% $0.000000* 0 28 Aug 2023 Common Stock 3,319 $16.96 Direct F4
transaction AMPH Employee Stock Option (right to buy) Options Exercise $0 -5,497 -100% $0.000000* 0 28 Aug 2023 Common Stock 5,497 $20.23 Direct F4
transaction AMPH Employee Stock Option (right to buy) Options Exercise $0 -20,000 -55% $0.000000 16,176 28 Aug 2023 Common Stock 20,000 $13.03 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 19, 2023.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.87 to $53.74, inclusive.The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
F3 The reported shares are held of record by the Yakob and Sunmoon Trust dated July 25, 2013 for which the reporting person serves as a trustee.
F4 Shares subject to the option are fully vested and immediately exercisable.
F5 Shares subject to the option vest in four equal annual installments beginning on March 16, 2021.